Aug 13, 2007 - Medtronic Inc. has entered into a definitive agreement with Biophan Technologies Inc. to acquire its MRI safety patents in a transaction worth $11 million in cash, as part of Medtronic’s strategy to develop solutions for the contraindication between pacemakers and MRI machines.
Under the terms of the agreement, Biophan will transfer to Medtronic its MRI safety patent portfolio, which includes technologies that make medical devices, such as pacemakers, safe for use with MRI.